abstract |
The invention relates to a non-symmetrically substituted tetrapirolic compound, to a process for its preparation and to its use as an active substance in pharmaceutical forms used in antitumor therapy. The compound according to the invention is 5 - [(3,4-methylenedioxy) phenyl] -10,15,20- (4-carboxymethylphenyl) -21,23H-porphine. |